Update on the challenges of treating trigeminal neuralgia

References

• International Headache Society. The International Classification of Headache Disorders: 2nd Edition. Cephalalgia. 2004;24 Suppl 1:9–160.
   Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
   PubMed Web of Science ®Google Scholar
• De Simone R, Marano E, Brescia Morra V, et al. A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis. Neurol Sci. 2005;26 Suppl 2:s150–s151.
   Google Scholar
• Maarbjerg S, Gozalov A, Olesen J, Bendtsen L. Trigeminal neuralgia – a prospective systematic study of clinical characteristics in 158 patients. Headache. 2014;54(10):1574–1582.
   PubMed Web of Science ®Google Scholar
• Szapiro J Jr, Sindou M, Szapiro J. Prognostic factors in microvascular decompression for trigeminal neuralgia. Neurosurgery. 1985;17(6):920–929.
   Web of Science ®Google Scholar
• Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia. 2008;28(2):174–181.
   PubMed Web of Science ®Google Scholar
• Sandell T, Eide PK. Effect of microvascular decompression in trigeminal neuralgia patients with or without constant pain. Neurosurgery. 2008;63(1):93–99.
   Web of Science ®Google Scholar
• Hagenacker T, Bude V, Naegel S, et al. Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia. J Headache Pain. 2014;15:78.
   PubMed Web of Science ®Google Scholar
• Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183–1190.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013–1028.
   PubMed Web of Science ®Google Scholar
• Cheshire WP. Trigeminal neuralgia feigns the terrorist. Cephalalgia. 2003;23(3):230.
   Web of Science ®Google Scholar
• Tolle T, Dukes E, Sadosky A. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract. 2006;6(3):153–160.
   PubMedGoogle Scholar
• Marbach JJ, Lund P. Depression, anhedonia and anxiety in temporomandibular joint and other facial pain syndromes. Pain. 1981;11(1):73–84.
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Jassim S, Bulman JS. A prospective, longitudinal study on patients with trigeminal neuralgia who underwent radiofrequency thermocoagulation of the Gasserian ganglion. Pain. 1999;79:51–58.
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM. Insights: Facts and Stories Behind Trigeminal Neuralgia. Gainesville, FL, USA: Trigeminal Neuralgia Association; 2006.
   Google Scholar
• Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA) – a prospective clinical study of SUNCT and SUNA. Brain. 2006;129 Pt 10:2746–2760.
   Google Scholar
• Zebenholzer K, Wober C, Vigl M, Wessely P, Wober-Bingol C. Facial pain and the second edition of the International Classification of Headache Disorders. Headache. 2006;46(2):259–263.
   Web of Science ®Google Scholar
• Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain. 2002;18(1):14–21.
   PubMed Web of Science ®Google Scholar
• Maarbjerg S, Wolfram F, Gozalov A, Olesen J, Bendtsen L. Significance of neurovascular contact in classical trigeminal neuralgia. Brain. 2015;138 Pt 2:311–319.
   Google Scholar
• Zakrzewska JM, Jorns TP, Spatz A. Patient led conferences – who attends, are their expectations met and do they vary in three different countries? Eur J Pain. 2009;13(5):486–491.
   Google Scholar
• Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29(3):265–267.
   PubMed Web of Science ®Google Scholar
• Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol. 1968;19(2):129–136.
   PubMedGoogle Scholar
• Nicol CF. A four year double-blind study of tegretol in facial pain. Headache. 1969;9(1):54–57.
   PubMedGoogle Scholar
• Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1966;15(2):129–136.
   PubMedGoogle Scholar
• Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy. 2000;20(8 Pt 2):152S–158S.
   PubMed Web of Science ®Google Scholar
• Martinez W, Ingenito A, Blakeslee M, Barkley GL, McCague K, D’Souza J. Efficacy, safety, and tolerability of oxcarbazepine monotherapy. Epilepsy Behav. 2006;9(3):448–456.
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223–230.
   PubMed Web of Science ®Google Scholar
• Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15:240–244.
   PubMed Web of Science ®Google Scholar
• Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev. 2007;2:CD006044.
   Google Scholar
• Ketter TA, Wang PW, Chandler RA, et al. Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash. J Clin Psychiatry. 2005;66(5):642–645.
   Web of Science ®Google Scholar
• Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain. 1987;28(1):45–50.
   PubMed Web of Science ®Google Scholar
• Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. 1998;51(2):611–614.
   PubMed Web of Science ®Google Scholar
• Taylor JC, Brauer S, Espir ML. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J. 1981;57(663):16–18.
   PubMed Web of Science ®Google Scholar
• Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacaine block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24(1):64–75.
   PubMed Web of Science ®Google Scholar
• Domingues RB, Kuster GW, Aquino CC. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr. 2007;65(3B):792–794.
   PubMed Web of Science ®Google Scholar
• Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16(6):740–744.
   PubMed Web of Science ®Google Scholar
• Fromm GH, Aumentado D, Terrence CF. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain. 1993;53(3):265–271.
   PubMed Web of Science ®Google Scholar
• Vilming ST, Lyberg T, Lataste X. Tizanidine in the management of trigeminal neuralgia. Cephalalgia. 1986;6(3):181–182.
   PubMed Web of Science ®Google Scholar
• Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manage. 2001;21(6):506–510.
   Web of Science ®Google Scholar
• Kanai A, Suzuki A, Kobayashi M, Hoka S. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97(4):559–563.
   PubMed Web of Science ®Google Scholar
• Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006;46(4):577–582.
   PubMed Web of Science ®Google Scholar
• Elsner F, Radbruch L, Gaertner J, Straub U, Sabatowski R. [Efficacy of opioid analgesia at the superior cervical ganglion in neuropathic head and facial pain]. Schmerz. 2006;20(4):268–272. German.
   PubMed Web of Science ®Google Scholar
• Cheshire WP. Can MRI distinguish injurious from innocuous trigeminal neurovascular contact? J Neurol Neurosurg Psychiatry. 2005;76(11):1470–1471.
   Web of Science ®Google Scholar
• Spatz AL, Zakrzewska JM, Kay EJ. Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions. Pain. 2007;131(3):302–310.
   Web of Science ®Google Scholar
• Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785–793.
   PubMed Web of Science ®Google Scholar
• Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005;65(8):1306–1308.
   PubMed Web of Science ®Google Scholar
• Zhang H, Lian Y, Ma Y, et al. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain. 2014;15:65.
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Palmer J, Ettlin DA, et al. Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia. Trials. 2013;14:402.
   PubMed Web of Science ®Google Scholar
• Convergence Pharmaceuticals. Convergence Pharmaceuticals’ Novel Sodium Channel Blocker CNV1014802 Shows Excellent Efficacy and Safety in Ground-Breaking Phase II Trigeminal Neuralgia Study [press release], 2014. Available from www.convergencepharma.com/userfiles/file/140616_Convergence_TGN%20vFINALFINAL.pdf. Accessed December 30, 2014.
   Google Scholar
• Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Long-lasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry. 2005;76(6):833–838.
   PubMed Web of Science ®Google Scholar
• Lefaucheur JP, Drouot X, Menard-Lefaucheur I, et al. Neurogenic pain relief by repetitive transcranial magnetic cortical stimulation depends on the origin and the site of pain. J Neurol Neurosurg Psychiatry. 2004;75(4):612–616.
   PubMed Web of Science ®Google Scholar